SCHEMBL4045170

SCHEMBL4045170

CS(=O)(=O)NCc1cccc(OBOc2cccc(CNS(C)(=O)=O)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 5/20 0.46
▸ BRD4 O60885 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ POLB P06746 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ NFATC1 O95644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172192 0.84 CYP19A1 (0.59) CYP19A1KMT2AMEN1GAAPOLB
SCHEMBL3321085 0.80 KMT2A (0.53) KMT2AMEN1POLBKDM4EALDH1A1
SCHEMBL27799067 0.79 BRD4 (0.44) CYP19A1BRD4KMT2AMEN1GAA
SCHEMBL5725662 0.77 PPARA (0.54) KMT2APOLBKDM4ETSHRRECQL
SCHEMBL7556647 0.76 SMN1; SMN2 (0.50) CYP19A1KMT2AMEN1POLBALDH1A1
SCHEMBL4043640 0.75 ALDH1A1 (0.51) POLBKDM4EALDH1A1RAB9ASMN1; SMN2
SCHEMBL27811793 0.75 CYP19A1 (0.51) CYP19A1BRD4KMT2APOLBKDM4E
SCHEMBL13462548 0.75 CYP19A1 (0.51) CYP19A1BRD4KMT2APOLBKDM4E
SCHEMBL8265344 0.75 CYP19A1 (0.56) CYP19A1BRD4KMT2AMEN1POLB
SCHEMBL1542377 0.73 CYP19A1 (0.61) CYP19A1BRD4KMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2020404-A1 Cyanomethyl substituted N-Acyl Tryptamines Bayer Schering Pharma Aktiengesellschaft (DE) 2009-02-04 — — EP disclosed
Send feedback